NCT06258642 2025-08-20
Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC
Fudan University
Phase NA Recruiting
Clinical Trials
8 trialsNCT06188650 2024-01-03
The Efficacy and Safety of Drug Loaded Microsphere Bronchial Artery Chemoembolization (DEB-BACE) Combined With Anlotinib and Adebelimumab in the Third Line Treatment of Advanced NSCLC: a Prospective, Single Arm, Single Center, Exploratory Clinical Study
Ningbo Medical Center Lihuili Hospital
Phase NA Recruiting
NCT04985851 2023-12-01
To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.
Shanghai Chest Hospital
Phase NA Unknown
NCT05218759 2022-02-01
Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC
Shanghai Chest Hospital
Phase NA Unknown
NCT04731909 2021-02-10
Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer
Third Military Medical University
Phase NA Unknown
NCT03769805 2019-10-22
CSOAIMTOAN
The First Affiliated Hospital with Nanjing Medical University
Phase NA Unknown
NCT03671538 2018-09-17
Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and Cisplatin
The First Affiliated Hospital of Nanchang University
Phase NA Unknown
NCT03602027 2018-07-26
Phase I Study of the Combination of Anlotinib With Gefitinib
Second Affiliated Hospital of Nanchang University
Phase NA Unknown